Infliximab treatment for resist Achilles tendonitis
Saudi Medical Journal. 2009; 30 (9): 1228-1230
en Inglés
| IMEMR
| ID: emr-102317
ABSTRACT
UndifFerentiated spondyloarthropathies [USPA] can sometimes be refractory to usual disease modifying agents. Anti-tumor necrosis factor [TNF] -alpha agents have been shown to be effective in spondyloarthropathies. Few articles described the efficacy of TNF-alpha antagonists in USPA. Our patient had refractory Achilles tendonitis as an early manifestation of USPA which responded dramatically to infliximab treatment
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Imagen por Resonancia Magnética
/
Factor de Necrosis Tumoral alfa
/
Tendinopatía
/
Antiinflamatorios
/
Anticuerpos Monoclonales
Tipo de estudio:
Informe de Casos
Límite:
Animales
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Saudi Med. J.
Año:
2009
Similares
MEDLINE
...
LILACS
LIS